JP2014500250A5 - - Google Patents

Download PDF

Info

Publication number
JP2014500250A5
JP2014500250A5 JP2013537902A JP2013537902A JP2014500250A5 JP 2014500250 A5 JP2014500250 A5 JP 2014500250A5 JP 2013537902 A JP2013537902 A JP 2013537902A JP 2013537902 A JP2013537902 A JP 2013537902A JP 2014500250 A5 JP2014500250 A5 JP 2014500250A5
Authority
JP
Japan
Prior art keywords
poly
acetylglucosamine
composition according
deacetylated
nucleic acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2013537902A
Other languages
English (en)
Japanese (ja)
Other versions
JP6029591B2 (ja
JP2014500250A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2011/059558 external-priority patent/WO2012061803A2/en
Publication of JP2014500250A publication Critical patent/JP2014500250A/ja
Publication of JP2014500250A5 publication Critical patent/JP2014500250A5/ja
Application granted granted Critical
Publication of JP6029591B2 publication Critical patent/JP6029591B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2013537902A 2010-11-06 2011-11-07 ナノポリマーをベースとした核酸送達のための組成物および方法 Expired - Fee Related JP6029591B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US41086310P 2010-11-06 2010-11-06
US61/410,863 2010-11-06
US41135810P 2010-11-08 2010-11-08
US61/411,358 2010-11-08
PCT/US2011/059558 WO2012061803A2 (en) 2010-11-06 2011-11-07 Compositions and methods for nanopolymer-based nucleic acid delivery

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2016080377A Division JP2016164181A (ja) 2010-11-06 2016-04-13 ナノポリマーをベースとした核酸送達のための組成物および方法

Publications (3)

Publication Number Publication Date
JP2014500250A JP2014500250A (ja) 2014-01-09
JP2014500250A5 true JP2014500250A5 (enExample) 2015-02-05
JP6029591B2 JP6029591B2 (ja) 2016-11-24

Family

ID=46025153

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2013537902A Expired - Fee Related JP6029591B2 (ja) 2010-11-06 2011-11-07 ナノポリマーをベースとした核酸送達のための組成物および方法
JP2016080377A Pending JP2016164181A (ja) 2010-11-06 2016-04-13 ナノポリマーをベースとした核酸送達のための組成物および方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2016080377A Pending JP2016164181A (ja) 2010-11-06 2016-04-13 ナノポリマーをベースとした核酸送達のための組成物および方法

Country Status (10)

Country Link
US (3) US20130287853A1 (enExample)
EP (1) EP2635261B1 (enExample)
JP (2) JP6029591B2 (enExample)
CN (2) CN103282024A (enExample)
AU (3) AU2011323078B2 (enExample)
CA (1) CA2816999A1 (enExample)
ES (1) ES2763432T3 (enExample)
IL (1) IL226170B (enExample)
MX (1) MX358050B (enExample)
WO (1) WO2012061803A2 (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3000487B8 (en) 2007-02-19 2022-06-15 Marine Polymer Technologies, Inc. Hemostatic compositions and therapeutic regimens
US8858964B2 (en) 2010-04-15 2014-10-14 Marine Polymer Technologies, Inc. Anti-bacterial applications of poly-N-acetylglucosamine nanofibers
CN103282024A (zh) * 2010-11-06 2013-09-04 海洋聚合物技术公司 用于纳米聚合物基核酸递送的组合物和方法
US20140127310A1 (en) 2011-04-15 2014-05-08 Marine Polymer Technologies, Inc. Treatment of disease with poly-n-acetylglucosamine nanofibers
CA2968160C (en) * 2016-05-31 2024-01-02 Sachiko Sato Use of n-acetylglucosamine and derivatives thereof to treat muscle disorders
EP3693024A1 (en) * 2019-02-05 2020-08-12 Altona Diagnostics GmbH Control for nucleic acid preparation and/or detection methods
IT202200004574A1 (it) * 2022-03-10 2023-09-10 Sergio Ammendola Nanoparticelle di N-acetilglucosammina e loro applicazioni

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5057540A (en) 1987-05-29 1991-10-15 Cambridge Biotech Corporation Saponin adjuvant
US4912094B1 (en) 1988-06-29 1994-02-15 Ribi Immunochem Research Inc. Modified lipopolysaccharides and process of preparation
GB0126923D0 (en) * 2001-11-09 2002-01-02 Procter & Gamble Chitosan compositions
US7780873B2 (en) * 2004-02-23 2010-08-24 Texas A&M University System Bioactive complexes compositions and methods of use thereof
JP2005281239A (ja) * 2004-03-30 2005-10-13 Nippon Zeon Co Ltd 鶏用ｄｎａワクチン
US20060105049A1 (en) * 2004-11-12 2006-05-18 Valorisation Recherche Hscm & Universite De Montreal Folic acid-chitosan-DNA nanoparticles
US8063063B2 (en) 2006-03-23 2011-11-22 Novartis Ag Immunopotentiating compounds
WO2007109813A1 (en) 2006-03-23 2007-09-27 Novartis Ag Imidazoquinoxaline compounds as immunomodulators
US20100150960A1 (en) * 2006-09-22 2010-06-17 The United States Of America, As Represented By The Secretary,Department Of Health And Human Servi Compositions and methods for chitosan enhanced immune response
KR100882611B1 (ko) * 2006-11-14 2009-02-12 주식회사 키토라이프 표적 리간드로서 폴릭산이 도입된 유전자 전달체용저분자량 수용성 키토산 나노입자 및 이의 제조방법
BRPI0807065A2 (pt) * 2007-01-31 2017-03-21 Allergan Inc biomateriais novos para liberação de fármaco ocular e um método para fazer e usar os mesmos
US20100086613A1 (en) * 2008-10-03 2010-04-08 Chang-Jer Wu Chitosan vehicle and method for making same
US20100105139A1 (en) * 2008-10-27 2010-04-29 Remco Alexander Spanjaard Ligand Targeted Nanocapsules for the delivery of RNAi and other Agents
US20130210717A1 (en) * 2010-05-10 2013-08-15 Corporation De L'ecole Polytechnique De Montreal Gene therapy for diabetes with chitosan-delivered plasmid encoding glucagon-like peptide 1
CN103282024A (zh) * 2010-11-06 2013-09-04 海洋聚合物技术公司 用于纳米聚合物基核酸递送的组合物和方法

Similar Documents

Publication Publication Date Title
JP2014500250A5 (enExample)
RU2014122432A (ru) Способ получения липидных наночастиц для доставки лекарственного средства
HK1208161A1 (en) Pharmaceutical nanoparticles showing improved mucosal transport
WO2009136763A3 (en) Nanoparticles for penetration of blood-brain barrier
JP2017165748A5 (enExample)
JP2015501791A5 (enExample)
BR112022019124A2 (pt) Composições e métodos para liberação de rna
WO2015152693A3 (ko) 신규 이중 나선 올리고 rna 및 이를 포함하는 섬유증 또는 호흡기 질환의 예방 또는 치료용 약학조성물
JP2010513363A5 (enExample)
JP2014508752A5 (enExample)
MX342439B (es) Metodos para producir nanoparticulas polimericas y formulaciones de ingredientes activos.
JP2012532992A5 (enExample)
WO2012170372A3 (en) Prna mutlivalent junction domain for use in stable multivalent rna nanoparticles
JP2015520197A5 (enExample)
JP2014514275A5 (enExample)
JP2012526134A5 (enExample)
IT1393040B1 (it) Processo per la preparazione di sospensioni stabili di nanoparticelle metalliche e sospensioni colloidali stabili cosi' ottenute
MX358050B (es) Composiciones y métodos para la entrega de ácido nucleico a base de nanopolímeros.
JP2013532729A5 (enExample)
MY165003A (en) Compositions of rotigotine, derivatives thereof, or pharmaceutically acceptable salts of rotigotine or its derivative
JP2015501791A (ja) 新規な遺伝子伝達用組成物
WO2013058482A3 (ko) 표적지향 및 치료가 가능한 다기능성 핵산 기반 항암제, 이의 제조 방법 및 이를 포함하는 항암제 조성물
FI3943070T3 (fi) Pitkävaikutteisia bedakiliiniformulaatioita
AR096854A1 (es) Composición farmacéutica para una liberación sostenida de lanreotide
JP2014510782A5 (enExample)